Email updates

Keep up to date with the latest news and content from Parasites & Vectors and BioMed Central.

This article is part of the series Protozoan parasites and cell death.

Open Access Highly Accessed Review

Impact of protozoan cell death on parasite-host interactions and pathogenesis

Carsten GK Lüder1*, Jenny Campos-Salinas2, Elena Gonzalez-Rey2 and Ger van Zandbergen3

  • * Corresponding author: Carsten GK Lüder clueder@gwdg.de

  • † Equal contributors

Author Affiliations

1 Institute for Medical Microbiology, Georg-August-University, Kreuzbergring 57, 37075 Göttingen, Germany

2 Instituto de Parasitologia y Biomedicina "Lopez-Neyra", Parque Tecnologico Ciencias de la Salud, Avenida Conocimiento, s/n, 18100 Armilla (Granada), Spain

3 Medical Microbiology and Hygiene, University of Ulm, Albert-Einstein-Allee 23, 89081 Ulm, Germany

For all author emails, please log on.

Parasites & Vectors 2010, 3:116  doi:10.1186/1756-3305-3-116


The electronic version of this article is the complete one and can be found online at: http://www.parasitesandvectors.com/content/3/1/116


Received:7 September 2010
Accepted:2 December 2010
Published:2 December 2010

© 2010 Lüder et al; licensee BioMed Central Ltd.

This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Abstract

PCD in protozoan parasites has emerged as a fascinating field of parasite biology. This not only relates to the underlying mechanisms and their evolutionary implications but also to the impact on the parasite-host interactions within mammalian hosts and arthropod vectors. During recent years, common functions of apoptosis and autophagy in protozoa and during parasitic infections have emerged. Here, we review how distinct cell death pathways in Trypanosoma, Leishmania, Plasmodium or Toxoplasma may contribute to regulation of parasite cell densities in vectors and mammalian hosts, to differentiation of parasites, to stress responses, and to modulation of the host immunity. The examples provided indicate crucial roles of PCD in parasite biology. The existence of PCD pathways in these organisms and the identification as being critical for parasite biology and parasite-host interactions could serve as a basis for developing new anti-parasitic drugs that take advantage of these pathways.

Introduction

Surprisingly, the question of how protozoan parasites die was neglected for a long time. Death of unicellular organisms was generally assumed to occur in an uncoordinated manner, and the processes involved in life-or-death decisions after treatment of parasites with chemotherapeutic agents or after induction of anti-parasitic immunity were therefore largely ignored. This was mostly due to the assumption that genetically determined death pathways in single-celled organisms are not favourable during evolution. With the detection, however, of cell death markers characteristic for metazoan programmed cell death (PCD) in diverse free-living and parasitic protozoa their pathways to death became a topic of intense research.

Three main cell death pathways, i.e. apoptosis, autophagic cell death and necrosis are now being generally considered [1] and it has been recently proposed to adopt the criteria of this classification also for PCD in protozoa [2]. Signs of apoptosis have been recognized in divergent unicellular parasites including kinetoplastids, apicomplexans, Trichomonas vaginalis, Giardia lamblia and Blastocystis hominis [3]. Markers for apoptosis in protozoan parasites include cell shrinkage, chromatin condensation, DNA and nuclear fragmentation, loss of mitochondrial membrane potential (MMP) and translocation of phosphatidylserine (PS) from the inner to the outer leaflet of the plasma membrane, while the plasma membrane is not disrupted at least during early stages [4]. In contrast, necrosis typically includes cell and organelle swelling, loss of plasma membrane integrity and only moderate chromatin condensation. Death by necrosis has been described in trypanosomes [5,6]. It has also been suggested for blood stages of Plasmodium [7] although this is still a matter of debate [8,9]. It is important to note that necrosis can occur in a regulated and physiological manner [10,11] and that it is nowadays at least not generally considered an uncontrolled form of death. Autophagy is an evolutionary conserved process which is presumably present in all protozoan parasites [12]. It is thought to function primarily as a survival mechanism which is used to provide the cell with energy during stress conditions including starvation, for organelle turnover, or for remodelling a cell during differentiation. However, when adverse conditions take too long and exceed cellular capacity, they could promote autophagic cell death [13]. Autophagic cell death is thus defined as cell death that occurs in the context of autophagy [1] and has been described in several protozoan parasites [14-19]. The most important step in autophagy is the formation of a new membrane to engulf cellular material (cargo) to be digested; this membrane that eventually forms a double membrane-surrounded vesicle is called the autophagosome.

One of the main questions that emerge from the detection of PCD pathways in protozoan parasites is how we can exploit these processes to combat some of the most widespread and deadly infectious agents of humans and animals more efficiently. Surely, detailed knowledge of the death-inducing signals and environmental conditions, the underlying transduction pathways, and the death effectors of protozoan parasites are not only of major scientific interest but will open a treasure chest for the development of new anti-parasitic therapies. Another major prerequisite for exploiting protozoan PCD pathways is however a clear picture about the physiological implications of parasite PCD on the host-pathogen interaction and the course of disease. During recent years, several common themes emerged on the physiological functions of cell death pathways in protozoa. In the following, we discuss current knowledge on how parasite PCD might regulate parasite densities within the host, how it is involved in stress responses and differentiation of protozoan parasites, and how it modulates host immunity to infection. Where applicable, the molecular mechanisms which govern these processes are also reviewed.

Regulation of parasite cell density by protozoan cell death

In order to establish sustained infections and transmission to new hosts, most parasites must avoid hyper-parasitism which would lead to the death of both the host and the parasite. Parasite numbers can be regulated by cell proliferation, cell cycle progression, or cell death. PCD in distinct protozoan parasites appears to determine cell densities at least under certain conditions (Table 1) and we hypothesize that it critically affects the parasite-host interaction by facilitating a sustained parasite-host equilibrium.

Table 1. Programmed cell death pathways and their possible roles in parasite biology and parasite-host interaction

Apoptosis and cell density of African trypanosomes

Trypanosoma brucei, i.e. the causative agent of sleeping sickness in humans and of nagana in cattle can undergo apoptosis in the mammalian bloodstream form (BSF) [20,21] and the procyclic form within the midgut of the tsetse fly [22,23]. In the mammalian bloodstream, parasitemia of T. brucei increases and decreases periodically and this is partially due to effective antibody-mediated immune responses of the host and antigenic variation of the major surface glycoprotein of the parasite. However, the cell density of T. brucei is also regulated in axenic cultures in the absence of any host-derived immune effectors. After reaching a cell density-dependent threshold, further expansion of the cell population is restricted by differentiation from the replicating long slender (LS) form to the non-dividing short stumpy (SS) form [24]. Subsequently, the parasite density even decreases and this is accompanied by the occurrence of morphological and biochemical markers for apoptosis [20]. Likewise, cultivation of T. brucei rhodesiense under high-density conditions correlates with the appearance of parasites displaying an apoptotic phenotype [21]. Interestingly, Figarella and colleagues showed that cell death in BSF trypanosomes can also be induced in vitro by prostaglandin (PG) D2 and its metabolites of the J series in a dose-dependent manner, but not by PGE2 or PGF2 [20,25]. The IC50 of PGD2, i.e. the concentration necessary to inhibit cell growth of T. brucei BSF by 50% is 3.7 μM and this corresponds to the occurrence of 50% TUNEL-positive parasites after treatment with 5 μM PGD2 [20]. Trypanosomes produce PGs including PGD2 and secrete them into the environment [26]. In addition, levels of PGs increase in plasma and cerebrospinal fluid during human infections with T. brucei although it remains unknown whether these are mainly derived from the host or the parasite [27]. It is thus tempting to speculate that African trypanosomes sense the total level of both parasite-derived and host-derived PGD2 and its metabolites in their environment initiating a cell death program that subsequently leads to a reduction in parasite density. Such self-restriction would be probably particularly relevant during late-stage trypanosomiasis when parasites have invaded the central nervous system (CNS) and where PG levels are particularly elevated [27]. In addition, the immune defence against T. brucei is limited within the CNS and may therefore not suffice to restrict parasite numbers efficiently enough to favour a sustained infection. However, it might well be that PG-induced apoptosis also contributes to the restriction in parasite numbers in the peripheral blood.

After uptake of SS forms with the blood meal and differentiation to procyclic insect stages, the parasite load within the tsetse midgut remains remarkably constant despite their ability to divide [23]. This density regulation might be accomplished by apoptotic cell death as observed after treatment of procyclic T. brucei rhodesiense in vitro with the lectin concanavalin A [22,28]. Most trypanosomes of an infective blood meal indeed die within the midgut via a death process that display features of apoptosis and are consequently unable to establish within the midgut [29]. It was thus hypothesized that apoptotic cell death can regulate densities of procyclic trypanosomes in the tsetse midgut [23,30]. A correlation between parasite density and the level of apoptosis has however not been established yet. An important question also remains whether apoptosis in procyclic trypanosomes has evolved as a mechanism of parasite-initiated self-regulation or rather represents a pathway to death that is induced by immune factors of the insect vector. The latter view is supported by findings that parasite apoptosis appears to be regulated by lectins and possibly also antimicrobial peptides present in the midgut of tsetse flies [31,32]. Furthermore, antioxidants within the blood meal protect procyclic trypanosomes from undergoing apoptosis indicating that reactive oxygen species (ROS) may also play a major role [33]. Whether such inhibition of parasite cell death leads to hyperparasitism and vector killing has, however, not been elucidated. Together, these data show that apoptosis of procyclic trypanosomes in the midgut of its vector may contribute to the parasite density in this compartment but it is unknown whether this PCD is a form of self-restriction in order to facilitate transmission to new hosts or is rather a form to die after immune attack.

Plasmodium densities in the insect vector

Ookinetes of the rodent malaria species Plasmodium berghei can show several typical features of apoptotic cells both in vivo within the midgut of female anopheline mosquitoes and in vitro [34,35]. It should be stressed that the exact conditions that favour the occurrence of apoptotic P. berghei ookinetes in vitro still need to be unravelled since in another study only very low levels of ookinetes displaying typical features of apoptosis were detected [36]. Signs of apoptosis have recently also been found in P. yoelli ookinetes in vitro [37], and work published by Arambage and colleagues suggests that also P. falciparum, i.e. the etiological agent of human malaria tropica, can undergo apoptosis in the insect midgut [35]. Plasmodium ookinetes differentiate from zygotes after the uptake of macro- and microgametocytes with the blood meal from an infective host and fertilization. Since they subsequently develop within the midgut epithelium into oocysts with up to thousands of sporozoites, survival of ookinetes critically determines the parasitic load of the malaria vector. Importantly, distinct caspase inhibitors inhibit the occurrence of apoptotic Plasmodium midgut stages in vitro and in vivo and increase the number of oocysts significantly [34]. Caspases take a central role in apoptosis of higher eukaryotes but homologues are absent in protozoa [38]. It is, therefore, at first sight surprising that caspase inhibitors abolish apoptosis in Plasmodium parasites; however, this could be due to the unspecific inhibition of non-caspase parasite proteases by the high inhibitor concentrations used in that study. In common with other protozoan parasites, Plasmodium spp. express multiple proteases including cysteine proteases [39] that might help to disassemble the parasitic cell. In addition, metacaspases, i.e. related cysteine proteases that share with caspases the presence of a conserved catalytic dyad have been described in several protozoa including Plasmodium falciparum [8,38]. Whether they are indeed involved in the cell death of protozoa is debated since they also fulfil PCD-unrelated functions. Recently, clan CA cysteine proteases which include the cathepsins and calpains have been implicated in a chloroquine-induced apoptotic pathway in P. falciparum as determined by inhibitor studies [40]. While these studies provide valuable clues to possible cell death pathways, further functional analyses are clearly needed to prove a putative involvement of these proteases in the execution of protozoan apoptotic pathways. In should also be stressed that caspase-independent pathways of apoptosis are present in metazoans as well. Whatever the molecules involved, the results outlined above suggest that apoptosis in Plasmodium zygotes and/or ookinetes indeed regulate the intensity of infection within the Anopheles vector although alternative explanations as for example, an indirect effect via the modulation of apoptosis in insect host cells cannot be completely ruled out. As discussed for procyclic trypanosomes, it also awaits future clarification whether apoptosis of Plasmodium midgut stages has evolved as a form of self-restriction and is required in order to avoid death of the anopheline vector before transmission of the parasite to new hosts is accomplished.

Signs of apoptosis have also been observed in blood stages of P. falciparum [8,41-43] but this was not confirmed by others [7,9]. It thus has to be clarified under which conditions malaria blood stages exactly can initiate an apoptotic program. Also the hypothesis that such apoptosis may contribute to regulating the number of infected red blood cells [42] remains to be supported.

Regulation of T. cruzi densities inside and outside cells?

Markers of apoptosis have been extensively found in T. cruzi, i.e. the etiological agent of Chagas' disease, both in vitro and in vivo [44-47]. Exponential growth of axenic epimastigotes (EPI), i.e. the proliferative stage present in the reduviid vector leads to a massive increase of parasites with an apoptotic phenotype which is associated with onset of a stationary growth phase [44,47]. Importantly, the appearance of apoptotic cell death can be prevented by resuspending exponentially grown parasites at decreased densities and this also delays the onset of the stationary growth phase [44]. This clearly indicates that the appearance of apoptotic T. cruzi EPI depends on parasite density and may indeed regulate the size of the population in vitro. However, whether this also occurs in the reduviid vector and how this might be regulated is currently unknown.

In T. cruzi-infected cardiomyocytes, a varying proportion of intracellular amastigotes (AMA) can also undergo apoptosis in vitro and in vivo [45,46]. The regulated death of intracellular parasites is remarkable since a 'silent' removal of the apoptotic cells as described for mammalian cells or extracellular parasites cannot occur making the further fate of the dead cell questionable. Whatever the fate is, the parasite is nevertheless withdrawn from the pool of replicating AMA and may hence restrict the further propagation inside the host cell. This view is supported by findings that in vitro the numbers of intracellular AMA of two different T. cruzi strains inversely correlate with the number of TUNEL-positive parasites [46]. For example, ~50% of TUNEL-positive AMA of the T. cruzi clone Y (a type II biodeme) led to only 4-5 parasites per cardiomyocyte within two days of intracellular development whereas ~25% TUNEL positivity led to 10-18 parasites of the Dm28c clone (a type I biodeme) per host cell. This suggests a reduction of the intracellular infection level by 50-75% via an apoptotic cell death and provides a first hint that the level of T. cruzi AMA cell death might indeed contribute to the regulation of the intracellular level of infection [46]. However, one has to stress that time course analyses of prolongued infections with T. cruzi clone Y in cardiomyocytes did not corroborate this hypothesis since after three days of infection a significant increase of intracellular parasites was observed despite continuously high levels of TUNEL-positive AMA [48]. Thus, whether and under which conditions apoptosis in T. cruzi determines the level of intracellular infection awaits future clarification.

In conclusion, several findings including correlations between parasite densities and the occurrence of apoptotic parasites, the sensing of population sizes via distinct environmental cues, and the ability to experimentally manipulate parasite densities by altering cell death pathways clearly support the hypothesis that PCD in protozoa contributes to their density regulation. Clear experimental evidence to support this hypothesis has mostly been obtained in vitro whereas the situation in vivo is more complex and may often be obscured by the immune response of the host. Thus, while there is evidence that parasite PCD can indeed regulate parasite populations a main question that remains still unanswered is whether apoptosis in these parasites has evolved as a mechanism to determine parasite densities. Alternatively, apoptotic pathways in protozoan parasites can also be favoured during evolution by contributing to the evasion of the hosts' immune response thereby increasing parasite fitness.

Immune silencing by apoptotic protozoan parasites

For the immune silencing potential of apoptotic protozoan parasites (Table 1) one has to take into account which lifestyle the parasite prefers. Being an obligate intracellular parasite preferring phagocytes as is the case for Leishmania, being intracellular in a wide range of host cells including phagocytic and non-phagocytic cells as is the case for Toxoplasma or a restricted range of non-phagocytic host cells as in the case of Plasmodium and T. cruzi as well as being extracellular as is the case for T. brucei.

Taking an obligate intracellular parasite preferring phagocytes, immune silencing of these host cells is a three step process [49]. This process is best described as the silent uptake of apoptotic mammalian cells into phagocytes [50-52]. First, apoptotic cells release "find-me" signals to recruit phagocytes to the site of apoptotic death [53]. Second, phagocytes recognize the presence of PS termed as "eat-me" signals on the membrane of apoptotic cells [51,54]. The final step is an active suppression of inflammation and immune response and can be termed as a "forget me" signal. Since apoptotic cells do not represent danger, their uptake does not result in the activation of antimicrobial effector functions of phagocytes [55,56]. This step is characterized by the release of anti-inflammatory cytokines such as TGF-β and IL-10 and lipids like the eicosanoids 15-S-HETE and lipoxin-A4 (LxA4). At the same time, pro-inflammatory cytokines like TNF and lipids like leukotriene-B4 are downregulated [50,52,57]. LxA4 enhances uptake of apoptotic cells and downregulates the production of IL-12 and the development of a TH-1 response [58].

Apoptotic Leishmania: An essential factor for successful infection

Taking Leishmania as a prototypic obligate intracellular parasite living inside phagocytes it has been demonstrated that Leishmania targets this three step process in at least two phases of establishing intracellular survival [49]. First L. major promastigotes produce a "find me" signal termed Leishmania chemotactic factor (LCF) recruiting its first host cell, i.e. the neutrophil (PMN) [59]. Moreover, it was shown that successful PMN invasion depends on the expression of the "eat me" signal PS on a sub-population of apoptotic parasites. After depleting the apoptotic parasites from a virulent population, L. major do not survive in phagocytes in vitro and lose their disease inducing ability in vivo [60,61]. It was also shown that promastigote survival depends on the PMN production of a "forget me" signal. PMN interaction with PS-positive promastigotes induce the production of TGF-β downregulating inflammatory TNF. Moreover, interaction with viable promastigotes alone induces a TNF dependent killing of intracellular promastigotes [60]. In the second phase of infection, Leishmania promastigotes infect macrophages and differentiate into the disease propagating multiplying amastigote form. Being first inside PMN these promastigote-infected cells start producing a "find me" signal in the form of MIP-1β specifically recruiting macrophages. At the same time infected PMN gradually becomes apoptotic and PS-positive. L. major can now use PMN as a 'Trojan horse' for a successful silent entry into macrophages [62,63]. As in the first phase of PMN infection this 'Trojan horse' strategy is mediated via the PS "eat me" signal on apoptotic PMN and "forget me" signals in the form of TGF-β produced by macrophages [62]. In vivo imaging has contributed a second evasion mechanism, recently termed 'Trojan rabbit' strategy, where parasites escape dying neutrophils to infect macrophages [63,64]. Disease propagation is mediated by amastigotes that were suggested to use PS expression as a form of apoptotic mimicry [65]. Here it was demonstrated that mouse-derived amastigotes are PS-positive and viable and that the presence of PS mediates a TGF-β dependent virulence of the amastigotes [65].

Immune silencing and trypanosomes

When analyzing the expression of PS on T. cruzi it was found that the apoptotic "eat me" signal was only present on the infective trypomastigotes (TRY), but not on the epimastigotes or intracellular amastigotes. In addition, it was demonstrated that the infective trypomastigotes uses a PS-dependent induction of TGF-β, thereby downregulating anti-parasitic activity of iNOS, enabling survival inside macrophages [66]. Moreover, T. cruzi has evolved a second evasion strategy based on the anti-inflammatory effect of TGF-β. In an experimental model for Chagas' disease it was found that the parasites induce an intense lymphocyte apoptosis [67]. Subsequently, this group demonstrated that the interaction of apoptotic but not necrotic lymphoyctes drives parasite growth in a TGF-β dependent manner [68]. Inhibiting the anti-inflammatory properties of TGF-β using cyclooxygenase inhibitors abolishes the pro-parasitic effect of apoptotic cell-macrophage interaction [68]. In a similar fashion injection of apoptotic neutrophils prior to Leishmania infection boost the parasitic growth [69].

As discussed above, T. brucei initiate cell death in the SS form which do not replicate and is unable to re-differentiate into replicating LS. The reason for this at first seemed unclear but it has been speculated that it constitutes a second control point after terminal differentiation [20]. Here, we speculate that it may rather represent a means to modulate the host's immune response to the parasite, since a continuously high number of stumpy parasites may favour an overwhelming inflammatory response with detrimental effects for both the parasite and the host. Apoptotic T. brucei gambiense have indeed been shown to dampen the inflammatory response of human macrophages [70].

Immune silencing and Toxoplasma

Inducible nitric oxide synthase (iNOS) regulation of nitric oxide (NO) also controls T. gondii growth. PS-expression on T. gondii was shown to induce TGF-β production by macrophages. The PS-binding protein Annexin-A5 reactivates the NO production and leads to the killing of T. gondii [71]. Therefore, an autocrine effect of TGF-β results in iNOS degradation, actin filament (F-actin) depolymerization and lack of nuclear factor-κB (NF-κB) in the nucleus contributing to PS-dependent T. gondii survival [71]. All these features can be reverted by TGF-β neutralizing antibody treatment. Recently, another mechanism involving PCD in the form of autophagy was shown to enhance intracellular T. gondii proliferation. T. gondii infection of both HeLa cells and primary fibroblasts induces host cell autophagy, dependent on ATG5 but independent of host mTOR signaling. Subsequently, this pathogen exploits the nutritive function of host autophagy to enhance its intracellular growth [72].

Immune silencing and Plasmodium

In contrast to the protozoan parasites mentioned above, for Plasmodium different hallmarks of apoptotic cell death have been recognized [35,73], but an immune silencing function has not yet been described. Since Plasmodium parasite stages do not need to immunologically silence phagocytes for a productive infection, it is not yet clear how PS-expression detected on different parasite stages can contribute in the parasites pathogenesis. Interestingly, the liver stage of the parasite hides inside a PS-negative bleb derived of hepatocytes to silently spread the parasites back into the blood circulation system [74].

Autophagy, recycling of organelles, and parasite differentiation

Protozoan parasites possess complex life cycles and are regularly transmitted between completely different host species. The diverse environments of different hosts but also different life styles of the same parasite species within a given host require extensive parasite adaptations and differentiation. During recent years, autophagy in protozoa has emerged as crucial mechanisms during these processes (Table 1). Whether autophagy during parasite differentiation can also culminate in autophagic cell death, however, is still unclear.

Differentiation in Leishmania parasites

Database searches have identified homologues of autophagy related genes (ATG) in Leishmania parasites [75-77]. The coordinated action of ATG products regulates formation of autophagosomes, i.e. those organelles that contain the cellular cargo to be digested (see above). In both mammals and yeast, autophagosomes are formed by two different pathways: one involves ATG8, the other ATG12 and ATG5. Upstream of the autophagosome formation, TOR (target of rapamycin) kinases control cell growth in higher eukaryotes in response to nutrients, energy conditions, and growth factors, initiating or not autophagy. In L. major, all ATG proteins of the two ubiquitination cascades are present (reviewed by [12]). Functional complementation in S. cerevisiae ATG mutants demonstrated that homologues of ATG5, ATG8, ATG10 and ATG12 could replace their yeast counterparts [12].

It has been demonstrated that autophagy mediates differentiation in L. major and L. mexicana [75,76]. Based on GFP-labeled ATG8 that specifically label autophagosomes in S. cerevisiae it was demonstrated that an increase in the abundance of autophagosomes play a role in L. mexicana differentiation of procyclic promastigotes into metacyclics and their subsequent differentiation to disease propagating AMA [76]. In addition, it was demonstrated that cysteine peptidases CPA and CPB are essential in this process and can be blocked by the compound K11777 [76]. In mutant parasites without CPA and CPB, promastigotes have an enhanced number of autophagosome-containing lysosomes. Although these mutated parasites survived, stage differentiation into AMA was almost completely blocked. Moreover, it was demonstrated that by inactivation of the L. major VPS4 gene, late stage endosomal sorting was blocked resulting in an accumulation of cytosolic autophagosomes that could not be processed further. As a result, Lm-vps4 mutants were less able to survive under autophagy inducing conditions such as nutrient deprivation and these parasites were unable to differentiate into metacyclic promastigotes [75]. It has not yet been described whether autophagy in Leishmania can also result in PS-positivity and death.

Organelle recycling and differentiation in T. brucei sp

As other protozoan parasites, T. brucei has to adapt to completely different environments in different hosts. In mammals, LS parasites are adapted to the rich glucose environment of the blood [78], and they undergo rapid multiplication. Their energy metabolism depends exclusively on glycolysis, which takes place within glycosomes [79]. In contrast, SS parasites that accumulate at the peaks of parasitaemia do not divide, and activate at least some of the components required for fully active mitochondria as preadaptation to proline as the major energy source in the tsetse. After uptake with the tsetse blood meal, they complete the biochemical and morphological changes that culminate in the generation of a proliferative procyclic cell population in the vector midgut. Previous work shows that the metabolism and enzymatic contents of glycosomes but also their morphology and intracellular localization in BSF and procyclic forms differ considerably [80]. These studies revealed that old glycosomes were associated with lysosomes implicating microautophagy, and were finally completely disintegrated while new ones were built, resulting in a gradual shift [81]. Trypanosomes thus seem to have the machinery to specifically degrade glycosomes and probably mitochondria in a process called "glycophagy" [82]. These results confirm a role of autophagy in the differentiation and environmental adaptation of African trypanosomes.

Involvement of autophagy in T. cruzi differentiation

The most important triggers of differentiation of T. cruzi are high cell density and nutritional stress [83]. Cell density and nutritional stress are interconnected when the parasites reach stationary phase of growth in axenic cultures. Under these conditions, EPI undergo apoptosis (see above), although autophagy could be contributing to the increase in mortality during prolongued cultivation [47]. However, under conditions of serum deprivation, cytoplasmic vacuoles decorated with high concentrations of the ubiquitin-like ATG8.1, a characteristic feature of autophagy [47], can be observed. Mutation of the glycine residue at the C terminus of ATG8.1 abolishes accumulation, thus indicating processing by the cysteine peptidase ATG4 as observed in higher eukaryotes [84]. In T. cruzi, starvation of EPI occurs naturally in the gut of the insect vector, which is known to suffer long periods of lack of food (up to 12 months) [85]. Thus, autophagy could represent a crucial survival mechanism of T. cruzi in the gut of the insect vector.

During transformation of proliferating non-infective EPI into G0/G1-arrested metacyclic TRY (metacyclogenesis), EPI but not metacyclic TRY parasites massively die by a process resembling apoptosis (see above). This process also requires fast and extensive protein degradation and recycling of building blocks for the synthesis of new macromolecules. Recent results have shown an intense expression of ATG8.1 in differentiating EPI, suggesting that these cells are undergoing autophagy. In contrast, almost no ATG8.1 was expressed in normal EPI or in fully developed metacyclic TRY which suggests that autophagy is a very dynamic process [84].

Morphological and ultrastructural studies have shown that the main organelle that is transformed during metacyclogenesis are the reservosomes, the large endosomal compartments in EPI where proteins and lipids are accumulating [86]. Furthermore, reservosomes are absent in cell culture-derived AMA and TRY [86]. The reservosomal content is consumed during differentiation to metacyclics, when they shrink and finally disappear. Serine carboxypeptidase, i.e. a marker of reservosomes and ATG8.1 partially colocalize in the reservosomes during differentiation, a fact that is likely due to the delivery of the autophagosome content to the reservosomes/lysosomes [84]. These data strongly suggest that proteins accumulated in reservosomes are utilized by the EPI forms as energy source during differentiation and that autophagy may be crucial for their disappearance in the vertebrate stages.

Autophagy and autophagic cell death as a response to stress

During their transmission between different host species or changes of their life style within a given host, parasites do not only undergo differentiation processes but they also encounter cellular stress, e.g. temperature shifts, starvation, or anti-parasitic effector mechanisms (Table 1). Autophagy has been recognized during environmental adaptations of several protozoan parasites which may facilitate parasite survival under certain stress conditions. As in higher eukaryotes, however, there is also in protozoan parasites a duality between pro-survival and death-promoting roles of autophagy. In addition, autophagic cell death in parasites has also been described under stress conditions although its function for the biology of the respective parasites remains elusive.

Stress adaptation in T. brucei sp

Starvation is a physiological condition that trypanosomes have to face within the insect gut. It has been shown that limited amount of nutrients can be transduced by the serine/threonine kinase TOR which is then inhibited, inducing autophagy. Starvation of T. brucei in vitro, by growing parasites in nutrient-limited medium or rapamycin, a macrolide isolated from Streptomyces hygroscopicus that binds to TOR, induce the formation of autophagic organelles [87]. It is questionable, however, if rapamycin induces autophagy in T. brucei, because it does not disrupt the active TOR complex as observed in higher eukaryotes [88].

ROS are common mediators of PCD which are increased after nutritional stress and after treatment with stress-inducing drugs [89]. In BSF trypanosomes, ROS are produced during prostaglandin-induced apoptosis (see above) although when it reaches higher concentrations can induce necrosis [25]. Remarkably, during these processes, autophagic structures can be seen in parasites that try to eliminate damaged structures and survive [87]. Likewise, dihydroxyacetone (DHA) that is used as a carbon source at low concentrations can lead to a cell cycle arrest in the G2-phase and formation of autophagic and multilamellar structures at higher concentrations [15,90]. This process is accompanied by cell membrane permeability, formation of ROS, PS exposure and cell death [15,90].

Neuropeptides have been recently identified in mammals after T. brucei infection. These peptides are targeted to the parasite glycosome and induce autophagic cell death in BSFs but not procyclic forms [16]. Neuropeptide-mediated autophagic cell death in T. brucei is preceeded by an energy metabolism failure and can thus be considered as being stress-related. Although the effect of neuropeptides against LS or SS has to be determined, this is an example of density control that could also contribute to parasite differentiation (Figure 1; see also above). Differences between structure and abundance of glycosylphosphatidylinositol (GPIs), glycosylation patterns of surface proteins of BSFs and procyclic forms, different endocytosis rates, carbohydrate metabolism, and glycosome dependency presented by each stage may be involved in the differential susceptibility of different life-cycle stages to these molecules.

thumbnailFigure 1. Possible impact of protozoan PCD pathways in parasite biology and life-or-death decisions. Parasitism depends on check points that control the population of the parasites and the survival of the host. In this sense, the existence of different PCD mechanisms in protozoan parasites appears to be crucial and may regulate distinct biological processes that are decisive for the outcome of infection. From a physiological point of view, PCD pathways can determine cell densities and differentiation at least under certain conditions, both processes being inter-connected by the regulated cross-talk between apoptotic and autophagic pathways. On the other hand, the involvement of autophagy on organelle remodelling allows the parasites to accomplish their complex life cycles and to adapt to different environments. Regarding the parasite-host interaction, several parasites are able to dampen immune responses and colonize the different environments in the hosts using apoptotic signalling. Deregulation of these processes can lead to activation of a predominant death signalling pathway that might be used as an attractive therapeutic strategy.

Autophagy in the stress response of T. cruzi

Treatment of T. cruci with lysophospholipid analogues such as edelfosine or miltefosine leads to cytosolic membrane arrangements, mitochondrial swelling and appearance of concentric structures in EPI, i.e. the insect stage, resembling autophagosome-like structures [17]. Naphthoquinones derived from plants lead to signs of an apoptosis-like process but formation of atypical membrane structures in EPI and trypomastigotes (TRY) suggests also the involvement of autophagy [18]. Propolis, a bee product with microbicidal properties causes mitochondrial swelling in EPI, with new membrane structures inside this organelle and, in the cytosol, altered vacuoles, formation of myelinated structures, and reservosome disorganization [91]. This suggests a possible interference with lipid content and biosynthesis, and in macromolecules accumulation [92]. Using terpenic alcohols such as geranylgeraniol, endoplasmic reticulum disorganization, myelin-like structures and concentric membrane arrangements inside damaged mitochondria were observed in all stages of T. cruzi, suggesting autophagic events [93]. The ultrastructure of the parasites after treatment with these chemotherapeutic agents suggests autophagic cell death as a common phenotype although signs of necrosis and apoptosis were also observed [6]. This suggests the interplay of distinct death mechanisms through a cross-talking of signalling pathways as reported for mammalian cells (Figure 1) [94]. Recently, the molecular features of autophagy in T. cruzi have been characterized [84]. A bioinformatic analysis of the T. cruzi genome confirms the existence of all major genes of the ATG8 conjugation system (ATG3, ATG4, ATG7, ATG8), whereas the major components of the ATG12-ATG5 conjugation system (ATG12, ATG5, ATG10) are apparently lacking [95]. The reduced set of genes involved in regulation and signalling pathways of autophagy in trypanosomes as compared to other eukaryotes might reflect the early appearance of this process in evolution [96]. The two T. cruzi autophagins (ATG4 proteases) are expressed constitutively throughout the parasite life cycle and process two recombinant ATG8 homologues at the Gly residue [84]. Moreover, all the T. cruzi ATG4, and to a lesser extent ATG8 homologues substitute their yeast counterparts in functional assays [84]. These results show that ATG8 conjugation system in T. cruzi is highly similar to the mammalian one, suggesting evolutionary conservation of this autophagic pathway.

Conclusions

Over the past 10-15 years considerable progress has been made in the understanding how distinct PCD pathways in protozoan parasites may affect the biology of protozoan parasites and their interactions with mammalian hosts and invertebrate vectors (Figure 1). The appearance of parasites displaying markers of apoptosis or autophagy during distinct processes of parasite biology as well as functional evidences has fuelled the view that these PCD pathways play critical roles in the life style of parasitic protozoa. In contrast, the impact of parasite necrosis for parasite-host interactions and whether it can occur in a regulated fashion as described in metazoans [10,11] is completely unknown. There is now good evidence that densities of distinct trypanosomatids and apicomplexan parasites can correlate with the appearance of PCD markers indicative of apoptosis. It has to be stressed, however, that a definite proof for the concept of parasite density regulation by parasite apoptosis is still missing, especially in vivo. This will probably require the availability of mutant parasites that are deficient in distinct regulators or executors of apoptotic cell death indicating also the urgent need to characterize underlying molecular mechanisms of PCD in protozoan parasites. There are also clear indications that apoptotic parasites with PS present in the outer leaflet of their plasma membrane modulate host immunity by limiting the inflammatory response of the host. This can be viewed as a form of molecular mimicry by which parasites 'misuse' a pathway for the immunologically silent removal of PS-exposing cells of their mammalian hosts. Another common theme emerging from the examples discussed above is that autophagy is involved in the differentiation of protozoan parasites. In addition, autophagy and autophagic cell death appear to be common responses when parasites encounter environmental stress. Since differentiation often coincides with environmental stress, for example during transmission from mammalian hosts to vectors or vice versa the contribution of autophagy and/or autophagic cell death in these processes may not be clearly distinguishable in each case. Nevertheless, is has become clear that autophagy in protozoan parasites - as in metazoan - primarily promotes survival but can proceed to a programmed form of death if adverse conditions within a hostile environment exceed cellular capacity. Although we are certainly far away from a clear understanding, apoptosis and autophagy thus appear to play important roles in protozoan parasites and the interactions with their mammalian hosts and invertebrate vectors. A detailed knowledge of the underlying molecular mechanism might open the possibility to combat protozoan parasites efficiently by promoting their own death pathways.

Competing interests

The authors declare that they have no competing interests.

Authors' contributions

CL collected data and drafted the information on the occurrence of PCD in protozoan parasites and its impact on cell density regulation. He also coordinated the contributions of the different authors. JC-S collected data and contributed to the comparing of PCD in protozoan parasites and higher eukaryotes. EG-R collected data on autophagy and its impact for the course of infection and drafted the respective part of the manuscript. GvZ collected data on immune silencing by apoptotic protozoa and drafted the respective part of the manuscript. EG-R and GvZ contributed equally to this work. All authors read and approved the final manuscript.

Acknowledgements

The authors are members of COST action BM0802 'Life and death of protozoan parasites' and appreciate support from this action.

References

  1. Kroemer G, Galluzzi L, Vandenabeele P, Abrams J, Alnemri ES, Baehrecke EH, Blagosklonny MV, El-Deiry WS, Golstein P, Green DR, Hengartner M, Knight RA, Kumar S, Lipton SA, Malorni W, Nuñez G, Peter ME, Tschopp J, Yuan J, Piacentini M, Zhivotovsky B, Melino G, Nomenclature Committee on Cell Death 2009: Classification of cell death: recommendations of the Nomenclature Committee on Cell Death 2009.

    Cell Death Differ 2009, 16:3-11. PubMed Abstract | Publisher Full Text | PubMed Central Full Text OpenURL

  2. van Zandbergen G, Luder CG, Heussler V, Duszenko M: Programmed cell death in unicellular parasites: a prerequisite for sustained infection?

    Trends Parasitol 2010, 26:477-483. PubMed Abstract | Publisher Full Text OpenURL

  3. Bruchhaus I, Roeder T, Rennenberg A, Heussler VT: Protozoan parasites: programmed cell death as a mechanism of parasitism.

    Trends Parasitol 2007, 23:376-383. PubMed Abstract | Publisher Full Text OpenURL

  4. Jimenez-Ruiz A, Alzate JF, Macleod ET, Luder CG, Fasel N, Hurd H: Apoptotic markers in protozoan parasites.

    Parasit Vectors 2010, 3:104. PubMed Abstract | BioMed Central Full Text | PubMed Central Full Text OpenURL

  5. Kubata BK, Nagamune K, Murakami N, Merkel P, Kabututu Z, Martin SK, Kalulu TM, Huq M, Yoshida M, Ohnishi-Kameyama M, Kinoshita T, Duszenko M, Urade Y: Kola acuminata proanthocyanidins: a class of anti-trypanosomal compounds effective against Trypanosoma brucei.

    Int J Parasitol 2005, 35:91-103. PubMed Abstract | Publisher Full Text OpenURL

  6. Menna-Barreto RF, Salomao K, Dantas AP, Santa-Rita RM, Soares MJ, Barbosa HS, de Castro SL: Different cell death pathways induced by drugs in Trypanosoma cruzi: an ultrastructural study.

    Micron 2009, 40:157-168. PubMed Abstract | Publisher Full Text OpenURL

  7. Porter H, Gamette MJ, Cortes-Hernandez DG, Jensen JB: Asexual blood stages of Plasmodium falciparum exhibit signs of secondary necrosis, but not classical apoptosis after exposure to febrile temperature (40 C).

    J Parasitol 2008, 94:473-480. PubMed Abstract | Publisher Full Text OpenURL

  8. Meslin B, Barnadas C, Boni V, Latour C, De Monbrison F, Kaiser K, Picot S: Features of apoptosis in Plasmodium falciparum erythrocytic stage through a putative role of PfMCA1 metacaspase-like protein.

    J Infect Dis 2007, 195:1852-1859. PubMed Abstract | Publisher Full Text OpenURL

  9. Nyakeriga AM, Perlmann H, Hagstedt M, Berzins K, Troye-Blomberg M, Zhivotovsky B, Perlmann P, Grandien A: Drug-induced death of the asexual blood stages of Plasmodium falciparum occurs without typical signs of apoptosis.

    Microbes Infect 2006, 8:1560-1568. PubMed Abstract | Publisher Full Text OpenURL

  10. Festjens N, Vanden Berghe T, Vandenabeele P: Necrosis, a well-orchestrated form of cell demise: signalling cascades, important mediators and concomitant immune response.

    Biochim Biophys Acta 2006, 1757:1371-1387. PubMed Abstract | Publisher Full Text OpenURL

  11. Degterev A, Hitomi J, Germscheid M, Ch'en IL, Korkina O, Teng X, Abbott D, Cuny GD, Yuan C, Wagner G, Hedrick SM, Gerber SA, Lugovskoy A, Yuan J: Identification of RIP1 kinase as a specific cellular target of necrostatins.

    Nat Chem Biol 2008, 4:313-321. PubMed Abstract | Publisher Full Text OpenURL

  12. Kiel JA: Autophagy in unicellular eukaryotes.

    Philos Trans R Soc Lond B Biol Sci 2010, 365:819-830. PubMed Abstract | Publisher Full Text OpenURL

  13. Maiuri MC, Zalckvar E, Kimchi A, Kroemer G: Self-eating and self-killing: crosstalk between autophagy and apoptosis.

    Nature reviews 2007, 8:741-752. PubMed Abstract | Publisher Full Text OpenURL

  14. Bera A, Singh S, Nagaraj R, Vaidya T: Induction of autophagic cell death in Leishmania donovani by antimicrobial peptides.

    Mol Biochem Parasitol 2003, 127:23-35. PubMed Abstract | Publisher Full Text OpenURL

  15. Uzcategui NL, Carmona-Gutierrez D, Denninger V, Schoenfeld C, Lang F, Figarella K, Duszenko M: Antiproliferative effect of dihydroxyacetone on Trypanosoma brucei bloodstream forms: cell cycle progression, subcellular alterations, and cell death.

    Antimicrobial agents and chemotherapy 2007, 51:3960-3968. PubMed Abstract | Publisher Full Text | PubMed Central Full Text OpenURL

  16. Delgado M, Anderson P, Garcia-Salcedo JA, Caro M, Gonzalez-Rey E: Neuropeptides kill African trypanosomes by targeting intracellular compartments and inducing autophagic-like cell death.

    Cell Death Differ 2009, 16:406-416. PubMed Abstract | Publisher Full Text OpenURL

  17. Santa-Rita RM, Lira R, Barbosa HS, Urbina JA, de Castro SL: Anti-proliferative synergy of lysophospholipid analogues and ketoconazole against Trypanosoma cruzi (Kinetoplastida: Trypanosomatidae): cellular and ultrastructural analysis.

    J Antimicrob Chemother 2005, 55:780-784. PubMed Abstract | Publisher Full Text OpenURL

  18. Menna-Barreto RF, Correa JR, Cascabulho CM, Fernandes MC, Pinto AV, Soares MJ, De Castro SL: Naphthoimidazoles promote different death phenotypes in Trypanosoma cruzi.

    Parasitology 2009, 136:499-510. PubMed Abstract | Publisher Full Text OpenURL

  19. Totino PR, Daniel-Ribeiro CT, Corte-Real S, de Fatima Ferreira-da-Cruz M: Plasmodium falciparum: erythrocytic stages die by autophagic-like cell death under drug pressure.

    Exp Parasitol 2008, 118:478-486. PubMed Abstract | Publisher Full Text OpenURL

  20. Figarella K, Rawer M, Uzcategui NL, Kubata BK, Lauber K, Madeo F, Wesselborg S, Duszenko M: Prostaglandin D2 induces programmed cell death in Trypanosoma brucei bloodstream form.

    Cell Death Differ 2005, 12:335-346. PubMed Abstract | Publisher Full Text OpenURL

  21. Tsuda A, Witola WH, Ohashi K, Onuma M: Expression of alternative oxidase inhibits programmed cell death-like phenomenon in bloodstream form of Trypanosoma brucei rhodesiense.

    Parasitol Int 2005, 54:243-251. PubMed Abstract | Publisher Full Text OpenURL

  22. Welburn SC, Dale C, Ellis D, Beecroft R, Pearson TW: Apoptosis in procyclic Trypanosoma brucei rhodesiense in vitro.

    Cell Death Differ 1996, 3:229-236. PubMed Abstract OpenURL

  23. Welburn SC, Maudlin I: Control of Trypanosoma brucei brucei infections in tsetse, Glossina morsitans.

    Med Vet Entomol 1997, 11:286-289. PubMed Abstract | Publisher Full Text OpenURL

  24. Vassella E, Reuner B, Yutzy B, Boshart M: Differentiation of African trypanosomes is controlled by a density sensing mechanism which signals cell cycle arrest via the cAMP pathway.

    J Cell Sci 1997, 110(Pt 21):2661-2671. PubMed Abstract | Publisher Full Text OpenURL

  25. Figarella K, Uzcategui NL, Beck A, Schoenfeld C, Kubata BK, Lang F, Duszenko M: Prostaglandin-induced programmed cell death in Trypanosoma brucei involves oxidative stress.

    Cell Death Differ 2006, 13:1802-1814. PubMed Abstract | Publisher Full Text OpenURL

  26. Kubata BK, Duszenko M, Kabututu Z, Rawer M, Szallies A, Fujimori K, Inui T, Nozaki T, Yamashita K, Horii T, Urade Y, Hayaishi O: Identification of a novel prostaglandin f(2 alpha) synthase in Trypanosoma brucei.

    J Exp Med 2000, 192:1327-1338. PubMed Abstract | Publisher Full Text | PubMed Central Full Text OpenURL

  27. Pentreath VW, Rees K, Owolabi OA, Philip KA, Doua F: The somnogenic T lymphocyte suppressor prostaglandin D2 is selectively elevated in cerebrospinal fluid of advanced sleeping sickness patients.

    Trans R Soc Trop Med Hyg 1990, 84:795-799. PubMed Abstract | Publisher Full Text OpenURL

  28. Welburn SC, Lillico S, Murphy NB: Programmed cell death in procyclic form Trypanosoma brucei rhodesiense--identification of differentially expressed genes during con A induced death.

    Mem Inst Oswaldo Cruz 1999, 94:229-234. PubMed Abstract | Publisher Full Text OpenURL

  29. Welburn SC, Barcinski MA, Williams GT: Programmed cell death in trypanosomatids.

    Parasitol Today 1997, 13:22-26. PubMed Abstract | Publisher Full Text OpenURL

  30. Duszenko M, Figarella K, Macleod ET, Welburn SC: Death of a trypanosome: a selfish altruism.

    Trends Parasitol 2006, 22:536-542. PubMed Abstract | Publisher Full Text OpenURL

  31. Maudlin I, Welburn SC: Lectin mediated establishment of midgut infections of Trypanosoma congolense and Trypanosoma brucei in Glossina morsitans.

    Trop Med Parasitol 1987, 38:167-170. PubMed Abstract OpenURL

  32. Hu Y, Aksoy S: An antimicrobial peptide with trypanocidal activity characterized from Glossina morsitans morsitans.

    Insect Biochem Mol Biol 2005, 35:105-115. PubMed Abstract | Publisher Full Text OpenURL

  33. MacLeod ET, Maudlin I, Darby AC, Welburn SC: Antioxidants promote establishment of trypanosome infections in tsetse.

    Parasitology 2007, 134:827-831. PubMed Abstract | Publisher Full Text OpenURL

  34. Al-Olayan EM, Williams GT, Hurd H: Apoptosis in the malaria protozoan, Plasmodium berghei: a possible mechanism for limiting intensity of infection in the mosquito.

    Int J Parasitol 2002, 32:1133-1143. PubMed Abstract | Publisher Full Text OpenURL

  35. Arambage SC, Grant KM, Pardo I, Ranford-Cartwright L, Hurd H: Malaria ookinetes exhibit multiple markers for apoptosis-like programmed cell death in vitro.

    Parasit Vectors 2009, 2:32. PubMed Abstract | BioMed Central Full Text | PubMed Central Full Text OpenURL

  36. Le Chat L, Sinden RE, Dessens JT: The role of metacaspase 1 in Plasmodium berghei development and apoptosis.

    Mol Biochem Parasitol 2007, 153:41-47. PubMed Abstract | Publisher Full Text | PubMed Central Full Text OpenURL

  37. Pollitt LC, Colegrave N, Khan SM, Sajid M, Reece SE: Investigating the evolution of apoptosis in malaria parasites: the importance of ecology.

    Parasit Vectors 2010, 3:105. PubMed Abstract | BioMed Central Full Text OpenURL

  38. Nedelcu AM: Comparative genomics of phylogenetically diverse unicellular eukaryotes provide new insights into the genetic basis for the evolution of the programmed cell death machinery.

    J Mol Evol 2009, 68:256-268. PubMed Abstract | Publisher Full Text OpenURL

  39. Klemba M, Goldberg DE: Biological roles of proteases in parasitic protozoa.

    Annu Rev Biochem 2002, 71:275-305. PubMed Abstract | Publisher Full Text OpenURL

  40. Ch'ng JH, Kotturi SR, Chong AG-L, Lear MJ, Tan KS-W: A programmed cell death pathway in the malaria parasite Plasmodium falciparum has general features of mammalian apoptosis but is mediated by clan CA cysteine proteases.

    Cell Death and Disease 2010, in press. OpenURL

  41. Picot S, Burnod J, Bracchi V, Chumpitazi BF, Ambroise-Thomas P: Apoptosis related to chloroquine sensitivity of the human malaria parasite Plasmodium falciparum.

    Trans R Soc Trop Med Hyg 1997, 91:590-591. PubMed Abstract | Publisher Full Text OpenURL

  42. Deponte M, Becker K: Plasmodium falciparum--do killers commit suicide?

    Trends Parasitol 2004, 20:165-169. PubMed Abstract | Publisher Full Text OpenURL

  43. Oakley MS, Kumar S, Anantharaman V, Zheng H, Mahajan B, Haynes JD, Moch JK, Fairhurst R, McCutchan TF, Aravind L: Molecular factors and biochemical pathways induced by febrile temperature in intraerythrocytic Plasmodium falciparum parasites.

    Infect Immun 2007, 75:2012-2025. PubMed Abstract | Publisher Full Text | PubMed Central Full Text OpenURL

  44. Ameisen JC, Idziorek T, Billaut-Mulot O, Loyens M, Tissier JP, Potentier A, Ouaissi A: Apoptosis in a unicellular eukaryote (Trypanosoma cruzi): implications for the evolutionary origin and role of programmed cell death in the control of cell proliferation, differentiation and survival.

    Cell Death Differ 1995, 2:285-300. PubMed Abstract OpenURL

  45. Zhang J, Andrade ZA, Yu ZX, Andrade SG, Takeda K, Sadirgursky M, Ferrans VJ: Apoptosis in a canine model of acute Chagasic myocarditis.

    J Mol Cell Cardiol 1999, 31:581-596. PubMed Abstract | Publisher Full Text OpenURL

  46. de Souza EM, Araujo-Jorge TC, Bailly C, Lansiaux A, Batista MM, Oliveira GM, Soeiro MN: Host and parasite apoptosis following Trypanosoma cruzi infection in in vitro and in vivo models.

    Cell Tissue Res 2003, 314:223-235. PubMed Abstract | Publisher Full Text OpenURL

  47. Jimenez V, Paredes R, Sosa MA, Galanti N: Natural programmed cell death in T. cruzi epimastigotes maintained in axenic cultures.

    Journal of cellular biochemistry 2008, 105:688-698. PubMed Abstract | Publisher Full Text OpenURL

  48. De Souza EM, Nefertiti AS, Bailly C, Lansiaux A, Soeiro MN: Differential apoptosis-like cell death in amastigote and trypomastigote forms from Trypanosoma cruzi-infected heart cells in vitro.

    Cell Tissue Res 2010, 341:173-180. PubMed Abstract | Publisher Full Text OpenURL

  49. van Zandbergen G, Solbach W, Laskay T: Apoptosis driven infection.

    Autoimmunity 2007, 40:349-352. PubMed Abstract | Publisher Full Text OpenURL

  50. Huynh ML, Fadok VA, Henson PM: Phosphatidylserine-dependent ingestion of apoptotic cells promotes TGF-beta1 secretion and the resolution of inflammation.

    J Clin Invest 2002, 109:41-50. PubMed Abstract | PubMed Central Full Text OpenURL

  51. Lauber K, Blumenthal SG, Waibel M, Wesselborg S: Clearance of apoptotic cells: getting rid of the corpses.

    Mol Cell 2004, 14:277-287. PubMed Abstract | Publisher Full Text OpenURL

  52. Voll RE, Herrmann M, Roth EA, Stach C, Kalden JR, Girkontaite I: Immunosuppressive effects of apoptotic cells.

    Nature 1997, 390:350-351. PubMed Abstract | Publisher Full Text OpenURL

  53. Lauber K, Bohn E, Krober SM, Xiao YJ, Blumenthal SG, Lindemann RK, Marini P, Wiedig C, Zobywalski A, Baksh S, Xu Y, Autenrieth IB, Schulze-Osthoff K, Belka C, Stuhler G, Wesselborg S: Apoptotic cells induce migration of phagocytes via caspase-3-mediated release of a lipid attraction signal.

    Cell 2003, 113:717-730. PubMed Abstract | Publisher Full Text OpenURL

  54. Fadok VA, Bratton DL, Frasch SC, Warner ML, Henson PM: The role of phosphatidylserine in recognition of apoptotic cells by phagocytes.

    Cell Death Differ 1998, 5:551-562. PubMed Abstract | Publisher Full Text OpenURL

  55. Meagher LC, Savill JS, Baker A, Fuller RW, Haslett C: Phagocytosis of apoptotic neutrophils does not induce macrophage release of thromboxane B2.

    J Leukoc Biol 1992, 52:269-273. PubMed Abstract | Publisher Full Text OpenURL

  56. Savill JS, Wyllie AH, Henson JE, Walport MJ, Henson PM, Haslett C: Macrophage phagocytosis of aging neutrophils in inflammation. Programmed cell death in the neutrophil leads to its recognition by macrophages.

    J Clin Invest 1989, 83:865-875. PubMed Abstract | Publisher Full Text | PubMed Central Full Text OpenURL

  57. Freire-de-Lima CG, Xiao YQ, Gardai SJ, Bratton DL, Schiemann WP, Henson PM: Apoptotic cells, through transforming growth factor-beta, coordinately induce anti-inflammatory and suppress pro-inflammatory eicosanoid and NO synthesis in murine macrophages.

    J Biol Chem 2006, 281:38376-38384. PubMed Abstract | Publisher Full Text OpenURL

  58. Aliberti J, Hieny S, Reis e Sousa C, Serhan CN, Sher A: Lipoxin-mediated inhibition of IL-12 production by DCs: a mechanism for regulation of microbial immunity.

    Nat Immunol 2002, 3:76-82. PubMed Abstract | Publisher Full Text OpenURL

  59. van Zandbergen G, Hermann N, Laufs H, Solbach W, Laskay T: Leishmania promastigotes release a granulocyte chemotactic factor and induce interleukin-8 release but inhibit gamma interferon-inducible protein 10 production by neutrophil granulocytes.

    Infect Immun 2002, 70:4177-4184. PubMed Abstract | Publisher Full Text | PubMed Central Full Text OpenURL

  60. van Zandbergen G, Bollinger A, Wenzel A, Kamhawi S, Voll R, Klinger M, Muller A, Holscher C, Herrmann M, Sacks D, Solbach W, Laskay T: Leishmania disease development depends on the presence of apoptotic promastigotes in the virulent inoculum.

    Proc Natl Acad Sci USA 2006, 103:13837-13842. PubMed Abstract | Publisher Full Text | PubMed Central Full Text OpenURL

  61. Wanderley JL, Pinto da Silva LH, Deolindo P, Soong L, Borges VM, Prates DB, de Souza AP, Barral A, Balanco JM, do Nascimento MT, Saraiva EM, Barcinski MA: Cooperation between apoptotic and viable metacyclics enhances the pathogenesis of Leishmaniasis.

    PLoS One 2009, 4:e5733. PubMed Abstract | Publisher Full Text | PubMed Central Full Text OpenURL

  62. van Zandbergen G, Klinger M, Mueller A, Dannenberg S, Gebert A, Solbach W, Laskay T: Cutting edge: neutrophil granulocyte serves as a vector for Leishmania entry into macrophages.

    J Immunol 2004, 173:6521-6525. PubMed Abstract | Publisher Full Text OpenURL

  63. Ritter U, Frischknecht F, van Zandbergen G: Are neutrophils important host cells for Leishmania parasites?

    Trends Parasitol 2009, 25:505-510. PubMed Abstract | Publisher Full Text OpenURL

  64. Peters NC, Egen JG, Secundino N, Debrabant A, Kimblin N, Kamhawi S, Lawyer P, Fay MP, Germain RN, Sacks D: In vivo imaging reveals an essential role for neutrophils in leishmaniasis transmitted by sand flies.

    Science 2008, 321:970-974. PubMed Abstract | Publisher Full Text | PubMed Central Full Text OpenURL

  65. Wanderley JL, Moreira ME, Benjamin A, Bonomo AC, Barcinski MA: Mimicry of apoptotic cells by exposing phosphatidylserine participates in the establishment of amastigotes of Leishmania (L) amazonensis in mammalian hosts.

    J Immunol 2006, 176:1834-1839. PubMed Abstract | Publisher Full Text OpenURL

  66. Damatta RA, Seabra SH, Deolindo P, Arnholdt AC, Manhaes L, Goldenberg S, de Souza W: Trypanosoma cruzi exposes phosphatidylserine as an evasion mechanism.

    FEMS Microbiol Lett 2007, 266:29-33. PubMed Abstract | Publisher Full Text OpenURL

  67. Lopes MF, da Veiga VF, Santos AR, Fonseca ME, DosReis GA: Activation-induced CD4 + T cell death by apoptosis in experimental Chagas' disease.

    J Immunol 1995, 154:744-752. PubMed Abstract | Publisher Full Text OpenURL

  68. Freire-de-Lima CG, Nascimento DO, Soares MB, Bozza PT, Castro-Faria-Neto HC, de Mello FG, DosReis GA, Lopes MF: Uptake of apoptotic cells drives the growth of a pathogenic trypanosome in macrophages.

    Nature 2000, 403:199-203. PubMed Abstract | Publisher Full Text OpenURL

  69. Ribeiro-Gomes FL, Otero AC, Gomes NA, Moniz-De-Souza MC, Cysne-Finkelstein L, Arnholdt AC, Calich VL, Coutinho SG, Lopes MF, DosReis GA: Macrophage interactions with neutrophils regulate Leishmania major infection.

    J Immunol 2004, 172:4454-4462. PubMed Abstract | Publisher Full Text OpenURL

  70. Mamani-Matsuda M, Rambert J, Malvy D, Lejoly-Boisseau H, Daulouede S, Thiolat D, Coves S, Courtois P, Vincendeau P, Mossalayi MD: Quercetin induces apoptosis of Trypanosoma brucei gambiense and decreases the proinflammatory response of human macrophages.

    Antimicrob Agents Chemother 2004, 48:924-929. PubMed Abstract | Publisher Full Text | PubMed Central Full Text OpenURL

  71. Seabra SH, de Souza W, Damatta RA: Toxoplasma gondii exposes phosphatidylserine inducing a TGF-beta1 autocrine effect orchestrating macrophage evasion.

    Biochem Biophys Res Commun 2004, 324:744-752. PubMed Abstract | Publisher Full Text OpenURL

  72. Wang Y, Weiss LM, Orlofsky A: Host cell autophagy is induced by Toxoplasma gondii and contributes to parasite growth.

    J Biol Chem 2009, 284:1694-1701. PubMed Abstract | Publisher Full Text | PubMed Central Full Text OpenURL

  73. van Zandbergen G, Luder CG, Heussler V, Duszenko M: Programmed cell death in unicellular parasites: a prerequisite for sustained infection?

    Trends Parasitol 2010, 26:477-83. PubMed Abstract | Publisher Full Text OpenURL

  74. Sturm A, Amino R, van de Sand C, Regen T, Retzlaff S, Rennenberg A, Krueger A, Pollok JM, Menard R, Heussler VT: Manipulation of host hepatocytes by the malaria parasite for delivery into liver sinusoids.

    Science 2006, 313:1287-1290. PubMed Abstract | Publisher Full Text OpenURL

  75. Besteiro S, Williams RA, Morrison LS, Coombs GH, Mottram JC: Endosome sorting and autophagy are essential for differentiation and virulence of Leishmania major.

    J Biol Chem 2006, 281:11384-11396. PubMed Abstract | Publisher Full Text OpenURL

  76. Williams RA, Tetley L, Mottram JC, Coombs GH: Cysteine peptidases CPA and CPB are vital for autophagy and differentiation in Leishmania mexicana.

    Mol Microbiol 2006, 61:655-674. PubMed Abstract | Publisher Full Text OpenURL

  77. Williams RA, Woods KL, Juliano L, Mottram JC, Coombs GH: Characterization of unusual families of ATG8-like proteins and ATG12 in the protozoan parasite Leishmania major.

    Autophagy 2009, 5:159-172. PubMed Abstract | Publisher Full Text | PubMed Central Full Text OpenURL

  78. Bakker BM, Westerhoff HV, Michels PA: Regulation and control of compartmentalized glycolysis in bloodstream form Trypanosoma brucei.

    Journal of bioenergetics and biomembranes 1995, 27:513-525. PubMed Abstract | Publisher Full Text OpenURL

  79. Hannaert V, Michels PA: Structure, function, and biogenesis of glycosomes in kinetoplastida.

    Journal of bioenergetics and biomembranes 1994, 26:205-212. PubMed Abstract | Publisher Full Text OpenURL

  80. Michels PA, Bringaud F, Herman M, Hannaert V: Metabolic functions of glycosomes in trypanosomatids.

    Biochimica et biophysica acta 2006, 1763:1463-1477. PubMed Abstract | Publisher Full Text OpenURL

  81. Herman M, Perez-Morga D, Schtickzelle N, Michels PA: Turnover of glycosomes during life-cycle differentiation of Trypanosoma brucei.

    Autophagy 2008, 4:294-308. PubMed Abstract OpenURL

  82. Rigden DJ, Herman M, Gillies S, Michels PA: Implications of a genomic search for autophagy-related genes in trypanosomatids.

    Biochem Soc Trans 2005, 33:972-974. PubMed Abstract | Publisher Full Text OpenURL

  83. Figueiredo RC, Rosa DS, Soares MJ: Differentiation of Trypanosoma cruzi epimastigotes: metacyclogenesis and adhesion to substrate are triggered by nutritional stress.

    The Journal of parasitology 2000, 86:1213-1218. PubMed Abstract | Publisher Full Text OpenURL

  84. Alvarez VE, Kosec G, Sant'Anna C, Turk V, Cazzulo JJ, Turk B: Autophagy is involved in nutritional stress response and differentiation in Trypanosoma cruzi.

    The Journal of biological chemistry 2008, 283:3454-3464. PubMed Abstract | Publisher Full Text OpenURL

  85. Kollien AH, Schaub GA: The development of Trypanosoma cruzi in triatominae.

    Parasitology today (Personal ed) 2000, 16:381-387. PubMed Abstract | Publisher Full Text OpenURL

  86. Soares MJ, Souto-Padron T, Bonaldo MC, Goldenberg S, de Souza W: A stereological study of the differentiation process in Trypanosoma cruzi.

    Parasitology research 1989, 75:522-527. PubMed Abstract | Publisher Full Text OpenURL

  87. Denninger V, Koopmann R, Muhammad K, Barth T, Bassarak B, Schonfeld C, Kilunga BK, Duszenko M: Kinetoplastida: model organisms for simple autophagic pathways?

    Methods Enzymol 2008, 451:373-408. PubMed Abstract | Publisher Full Text OpenURL

  88. Barquilla A, Crespo JL, Navarro M: Rapamycin inhibits trypanosome cell growth by preventing TOR complex 2 formation.

    Proc Natl Acad Sci USA 2008, 105:14579-14584. PubMed Abstract | Publisher Full Text | PubMed Central Full Text OpenURL

  89. Scherz-Shouval R, Shvets E, Fass E, Shorer H, Gil L, Elazar Z: Reactive oxygen species are essential for autophagy and specifically regulate the activity of Atg4.

    The EMBO journal 2007, 26:1749-1760. PubMed Abstract | Publisher Full Text | PubMed Central Full Text OpenURL

  90. Uzcategui NL, Denninger V, Merkel P, Schoenfeld C, Figarella K, Duszenko M: Dihydroxyacetone induced autophagy in African trypanosomes.

    Autophagy 2007, 3:626-629. PubMed Abstract | Publisher Full Text OpenURL

  91. Dantas AP, Salomao K, Barbosa HS, De Castro SL: The effect of Bulgarian propolis against Trypanosoma cruzi and during its interaction with host cells.

    Memorias do Instituto Oswaldo Cruz 2006, 101:207-211. PubMed Abstract OpenURL

  92. Cunha-e-Silva NL, Atella GC, Porto-Carreiro IA, Morgado-Diaz JA, Pereira MG, De Souza W: Isolation and characterization of a reservosome fraction from Trypanosoma cruzi.

    FEMS Microbiol Lett 2002, 214:7-12. PubMed Abstract | Publisher Full Text OpenURL

  93. Menna-Barreto RF, Laranja GA, Silva MC, Coelho MG, Paes MC, Oliveira MM, de Castro SL: Anti-Trypanosoma cruzi activity of Pterodon pubescens seed oil: geranylgeraniol as the major bioactive component.

    Parasitology research 2008, 103:111-117. PubMed Abstract | Publisher Full Text OpenURL

  94. Assuncao Guimaraes C, Linden R: Programmed cell deaths. Apoptosis and alternative deathstyles.

    European journal of biochemistry/FEBS 2004, 271:1638-1650. PubMed Abstract | Publisher Full Text OpenURL

  95. El-Sayed NM, Myler PJ, Bartholomeu DC, Nilsson D, Aggarwal G, Tran AN, Ghedin E, Worthey EA, Delcher AL, Blandin G, et al.: The genome sequence of Trypanosoma cruzi, etiologic agent of Chagas disease.

    Science (New York, NY) 2005, 309:409-415. OpenURL

  96. Herman M, Gillies S, Michels PA, Rigden DJ: Autophagy and related processes in trypanosomatids: insights from genomic and bioinformatic analyses.

    Autophagy 2006, 2:107-118. PubMed Abstract | Publisher Full Text OpenURL

  97. Li Q, Zhou Y, Yao C, Ma X, Wang L, Xu W, Wang Z, Qiao Z: Apoptosis caused by Hsp90 inhibitor geldanamycin in Leishmania donovani during promastigote-to-amastigote transformation stage.

    Parasitol Res 2009, 105:1539-1548. PubMed Abstract | Publisher Full Text OpenURL

  98. Alzate JF, Arias AA, Moreno-Mateos D, Alvarez-Barrientos A, Jimenez-Ruiz A: Mitochondrial superoxide mediates heat-induced apoptotic-like death in Leishmania infantum.

    Mol Biochem Parasitol 2007, 152:192-202. PubMed Abstract | Publisher Full Text OpenURL

  99. Raina P, Kaur S: Chronic heat-shock treatment driven differentiation induces apoptosis in Leishmania donovani.

    Mol Cell Biochem 2006, 289:83-90. PubMed Abstract | Publisher Full Text OpenURL

  100. Alzate JF, Alvarez-Barrientos A, Gonzalez VM, Jimenez-Ruiz A: Heat-induced programmed cell death in Leishmania infantum is reverted by Bcl-X(L) expression.

    Apoptosis 2006, 11:161-171. PubMed Abstract | Publisher Full Text OpenURL

  101. Moreira ME, Del Portillo HA, Milder RV, Balanco JM, Barcinski MA: Heat shock induction of apoptosis in promastigotes of the unicellular organism Leishmania (Leishmania) amazonensis.

    J Cell Physiol 1996, 167:305-313. PubMed Abstract | Publisher Full Text OpenURL